Fintech PR
Guangzhou Development District holds 2023 Saudi (Jazan) Special Investment Promotion and Exchange Forum
GUANGZHOU, China, Sept. 28, 2023 /PRNewswire/ — On September 25, 2023 Saudi (Jazan) Special Investment Promotion and Exchange Forum was held in Guangzhou Development District, also known as Huangpu District, situated in southern China. This exchange meeting between China and Saudi Arabia constituted the inaugural event following the visit of Guangdong delegation to Saudi Arabia in early September.
Nawaf AlWard, General Manager of the Investment Department of Jazan Royal Commission, noted that in recent years, Saudi Arabia has been steadfast in pursuing the “Vision 2030” strategy, the momentum of rapid economic development. The open foreign policy of Saudi Arabia has captivated the attention of foreign investors, particularly those from China. Therefore, the Royal Commission pledges unwavering support to assist corporations in establishing their presence and provide facilities for those on the ground.
Chen Zhiyong, Deputy Secretary of Huangpu District Committee of the CPC, articulated that the Guangzhou Development District is one of the most powerful, dynamic and efficient regions in the country. With extensive experience in investment promotion and industrial park construction, the region forms five 100-billion-level industrial clusters, including emerging information technology, automotive manufacturing, renewable energy, beauty and health, and new material, as well as three 50-billion level ones consisting of high-end equipment, biotechnology, and integrated circuits. This solid foundation is expected to facilitate the cooperation of production and energy between China and Saudi Arabia.
China-Saudi Jazan Industrial Zone, located in Jazan Industrial City in Saudi Arabia, adheres to a development strategy of “infrastructure advancement, industrial cluster, city-industry integration, and environmental protection”. This area spans 32 square kilometers, including a 30-square-kilometer industrial zone and a 2-square-kilometer residential area.
The Silk Road Industrial Services Co., Ltd. was jointly established by Guangzhou Development District, Ningxia Yinchuan Economic and Technological Development District, Royal Commission for Jubail and Yanbu (RCJY), and Saudi Aramco, responsible for attracting investment and other related work for the industrial luster zone.
Li Zhe, general manager of the Silk Road Industrial Services Co., Ltd., said that the industrial zone currently has facilities such as the Jazan Commercial Port, seawater desalination plant, and refinery. By meticulously integrating the eight pillar industries from the Guangzhou Development District with existing industry development plans of Jazan Industrial City, it targets at six predominant sectors, including metal smelting and processing, renewable energy, petrochemicals, marine wind energy equipment, intelligent home appliances, and white goods, along with the construction of specialized industrial parks within parks.
Jansson Victor Johan, Project Manager of Investment Department of Royal Commission at Jazan, also highlighted the region’s abundant natural gas, oil, and mineral resources as well as distinct cost advantages. To promote diversified economic development, special economic zones have been established in Jazan, along with a plethora of supportive policies on loans, taxes, and labor, which provide comprehensive service for foreign investors.
Xuzhuang Biotech Co., Ltd., based in Guangzhou Development District, recently signed a cooperation agreement with a Saudi agent. During this promotion event, the company’s foreign trade manager Zhang Shixian, conveyed keen enthusiasm for exploring the vast potential of the Saudi market.
Guangzhou Development District insists on a high-quality strategy for both “bringing in” and “going out”. By focusing on the development and construction of the Jazan Industrial Zone, the district maintains a high level of openness to foreign countries, actively explores new modes of international cooperation, and builds comprehensive international cooperation platforms such as China–Singapore, China–Europe, China–Russia, China–Israel, and China–Saudi Arabia relationships, to accelerate reciprocal investments.
In 2022, 76 new overseas investment projects were initiated in the Guangzhou Development District, leading Guangzhou in terms of volume. The projects encompassed a diverse array of industries, including biopharmaceuticals, supply chain logistics, and electronic equipment, and extended across 16 countries and regions. Chinese pledged investments in these projects reached $1.356 billion, accounting for over 80% of Guangzhou’s share. In 2022, the district attracted over $2.9 billion in foreign investment, with 135 Fortune 500 companies establishing 315 enterprises in the area.
Image Attachments Links:
Link: https://iop.asianetnews.net/view-attachment?attach-id=442515
Caption: Guangzhou Development District holds 2023 Saudi (Jazan) Special Investment Promotion and Exchange Forum.
Photo – https://mma.prnewswire.com/media/2234018/Forum.jpg
View original content:https://www.prnewswire.co.uk/news-releases/guangzhou-development-district-holds-2023-saudi-jazan-special-investment-promotion-and-exchange-forum-301941237.html
Fintech PR
Invitation to presentation of EQT AB’s Q1 Announcement 2024
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
Fintech PR
Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
Fintech PR
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News5 days ago
Letter from Gatemore Capital Management LLP to Elementis PLC
-
Latest News5 days ago
Shanghai Electric Releases ESG Report, Highlighting Sustainable Development Achievements in 2023
-
Latest News4 days ago
Hyosung Heavy Industries Ranked on BNEF’s Energy Storage Tier 1 List
-
Latest News4 days ago
Talino, Chemonics invest in startup Higala, the Philippines’ pioneering inclusive instant payment system
-
Latest News5 days ago
Report Finds that Huawei DigiTruck Training Helps Boost Income, Employment and Entrepreneurship
-
Latest News5 days ago
Zilch Partners with Amazon Web Services to Drive AI Innovation
-
Latest News3 days ago
LeddarTech Reports Annual Shareholder Meeting Results
-
Latest News4 days ago
SAR1.1 Billion Riyadh Real Estate Fund Launched by Ezdihar Real Estate Development & Al-Istithmar Capital